Pretreatment Lung Immune Prognostic Index Is a Prognostic Marker of Chemotherapy and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

BACKGROUND: Lung immune prognostic index (LIPI) was recently developed on the basis of the combination of baseline derived neutrophil to lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH). This index was demonstrated as a specific biomarker of immune checkpoint inhibitors for non-small cell lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Seigo, Ihara, Shouichi, Komuta, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396774/
https://www.ncbi.nlm.nih.gov/pubmed/30834050
http://dx.doi.org/10.14740/wjon1179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396774/
https://www.ncbi.nlm.nih.gov/pubmed/30834050
http://dx.doi.org/10.14740/wjon1179

Ejemplares similares